138 related articles for article (PubMed ID: 34261466)
1. Human papillomavirus (HPV) testing for cervical cancer screening in a middle-income country: comment on a large real-world implementation study in China.
Thomsen LT; Kjær SK
BMC Med; 2021 Jul; 19(1):165. PubMed ID: 34261466
[No Abstract] [Full Text] [Related]
2. Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study.
Zhao Y; Bao H; Ma L; Song B; Di J; Wang L; Gao Y; Ren W; Wang S; Wang HJ; Wu J
BMC Med; 2021 Jul; 19(1):164. PubMed ID: 34261463
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer prevention: Human papillomavirus testing as primary screening.
Desai S; Zhu MJ; Lapidos-Salaiz I
Cancer; 2022 Mar; 128(5):939-943. PubMed ID: 34767263
[TBL] [Abstract][Full Text] [Related]
4. [Human Papillomavirus: screening of cervical and anal cancers].
Pache B; Jacot-Guillarmod M; Hübner M; Mathevet P
Rev Med Suisse; 2022 Oct; 18(800):1950-1955. PubMed ID: 36259700
[TBL] [Abstract][Full Text] [Related]
5. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
[No Abstract] [Full Text] [Related]
6. Prevalence and Distribution of Vaccine-Preventable Genital Human Papillomavirus(HPV) Genotypes in Ghanaian Women Presenting for Screening.
Donkoh ET; Asmah RH; Agyemang-Yeboah F; Dabo EO; Wiredu EK
Cancer Control; 2022; 29():10732748221094721. PubMed ID: 35536890
[TBL] [Abstract][Full Text] [Related]
7. Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data.
Rebolj M; Cuschieri K; Mathews CS; Pesola F; Denton K; Kitchener H;
BMJ; 2022 May; 377():e068776. PubMed ID: 35640960
[TBL] [Abstract][Full Text] [Related]
8. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
[TBL] [Abstract][Full Text] [Related]
10. High risk HPV infection prevalence and associated cofactors: a population-based study in female ISSSTE beneficiaries attending the HPV screening and early detection of cervical cancer program.
Torres-Poveda K; Ruiz-Fraga I; Madrid-Marina V; Chavez M; Richardson V
BMC Cancer; 2019 Dec; 19(1):1205. PubMed ID: 31823749
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of human papillomavirus infection and genotyping for population-based cervical screening in developed regions in China.
Zhang Y; Wang Y; Liu L; Guo C; Liu Z; Nie S
Oncotarget; 2016 Sep; 7(38):62411-62424. PubMed ID: 27566561
[TBL] [Abstract][Full Text] [Related]
12. Coverage rate of cervical cytology and HPV DNA test for cervix cancer screening: Reappraisal on impact of COVID-19 outbreak.
Sookaromdee P; Wiwanitkit V
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S1020-S1021. PubMed ID: 38384106
[No Abstract] [Full Text] [Related]
13. Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania.
Şuteu O; Blaga ML; Nygård M; Leinonen MK; Nicula F; Păiş R; Coza D; Cadariu PA; Melnic A; Andreassen T; Hashim D; Weiderpass E
Eur J Cancer Prev; 2020 Mar; 29(2):141-148. PubMed ID: 31033568
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the detection rate of cervical lesion with TruScreen, LBC test and HPV test: A Real-world study based on population screening of cervical cancer in rural areas of China.
Ma Y; Di J; Bi H; Zhao Q; Qin T; Xu W; Liu Z; Yi N; Zhao J; Zhou D; Chen J; Yang Q
PLoS One; 2020; 15(7):e0233986. PubMed ID: 32634143
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
Wang HY; Lee D; Park S; Kim G; Kim S; Han L; Yubo R; Li Y; Park KH; Lee H
Asian Pac J Cancer Prev; 2015; 16(17):7633-40. PubMed ID: 26625774
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
[TBL] [Abstract][Full Text] [Related]
17. The time has come to implement primary human papillomavirus screening for cervical cancer in the United States.
Franco EL;
Cancer; 2023 Sep; 129(18):2765-2768. PubMed ID: 37347988
[No Abstract] [Full Text] [Related]
18. Prevention of Cervical Cancer in Low-Resource African Settings.
Mulongo M; Chibwesha CJ
Obstet Gynecol Clin North Am; 2022 Dec; 49(4):771-781. PubMed ID: 36328679
[TBL] [Abstract][Full Text] [Related]
19. HPV self-sampling for cervical cancer screening: a systematic review of values and preferences.
Nishimura H; Yeh PT; Oguntade H; Kennedy CE; Narasimhan M
BMJ Glob Health; 2021 May; 6(5):. PubMed ID: 34011537
[TBL] [Abstract][Full Text] [Related]
20. Prior cervical cytology and high-risk HPV testing results for 311 patients with invasive cervical adenocarcinoma: a multicenter retrospective study from China's largest independent operator of pathology laboratories.
Xie F; Zhang L; Zhao D; Wu X; Wei M; Zhang X; Wu X; Fang H; Xu X; Yang M; Qi D
BMC Infect Dis; 2019 Nov; 19(1):962. PubMed ID: 31711435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
